Hostname: page-component-7479d7b7d-767nl Total loading time: 0 Render date: 2024-07-12T01:02:36.187Z Has data issue: false hasContentIssue false
  • English
  • Français

Cerebral mechanisms of mood and behaviour1

Published online by Cambridge University Press:  09 July 2009

D. G. Grahame-Smith
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Psychological Medicine , Volume 6 , Issue 4 , February 1977 , pp. 523 - 528
Copyright
Copyright © Cambridge University Press 1977

References

REFERENCES

Akiskal, H. S. & McKinney, W. T. (1973). Depressive disorders: toward a unified hypothesis. Science 182, 20–29.Google Scholar
Cooper, J. R., Bloom, F. E. & Roth, R. H. (1970). The Biochemical Basis of Neuropharmacology, Chapter 9. Oxford University Press: London.Google Scholar
Grahame-Smith, D. G. (1973). Pharmacological aspects of schizophrenia. Biochemical Society Special Publications 1, 197–207.Google Scholar
Green, A. R. & Grahame-Smith, D. G. (1974). TRH potentiates behavioural changes following increased brain 5-hydroxytryptamine accumulation in rats. Nature 251, 524–526.CrossRefGoogle ScholarPubMed
Green, A. R. & Grahame-Smith, D. G. (1975). 5-hydroxy-tryptamine and other indoles in the central nervous system. In Handbook of Psychopharmacology, vol. 3 (ed. Iversen, S. D., Iversen, L. L. & Snyder, S. H.), pp. 169–245. Plenum Press: New York.Google Scholar
Green, A. R. & Grahame-Smith, D. G. (1976). The effect of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine. Nature 260, 487–491.CrossRefGoogle ScholarPubMed
Green, A. R., Heal, D. J. & Grahame-Smith, D. G. (1975). Lack of change in the sensitivity of rat caudate nucleus adenyl cyclase to dopamine when TRH and cycloheximide produce opposite effects on behavioural responses to certain centrally active drugs. In Chemical Tools in Catecholamine Research, vol. 2 (ed. Almgren, O., Carlsson, A. & Engel, J.), pp. 265–274. North Holland/American Elsevier.Google Scholar
Iversen, L. L. (1973). Monoamines in the mammalian central nervous system and the action of antidepressant drugs. Biochemical Society Special Publications 1, 81–96.Google Scholar
Moore, K. E. (1971). In Introduction to Psychopharmacology (ed. Rech, R. H. & Moore, K. E.), p. 117. Raven Press: New York.Google Scholar
Plotnikoff, N. P., Prange, A. J., Breese, G. R., Anderson, M.S. & Wilson, I. C. (1972). TRH: Enhancement of DOPA activity by a hypothalamic hormone. Science 178, 417–418.Google Scholar
Schildkraut, J. J. (1969). Rationale of some approaches used in the biochemical studies of the affective disorders: The pharmacological bridge. In Psychochemical Research in Man (ed. Mandell, A. J. & Mandell, M. P.). Academic Press: New York.Google Scholar
Shopsin, B., Wilk, S., Sathananthan, G., Gershon, S. & Davis, K. (1974). Catecholamines and affective disorders raised. A critical assessment. Journal of Nervous and Mental Disease 158, 369–383.CrossRefGoogle Scholar
Snyder, S. H., Banerjee, S. P., Yamamura, H. I. & Greenburg, D. (1974). Drugs, neurotransmitters and schizophrenia. Science 184, 1243–1253.Google Scholar
Van Praag, H. M. (1974). Towards a biochemical typology of depression? Pharmakopsychiatria 7, 281–292.CrossRefGoogle Scholar